Santos-Preciado JI, Franco-Paredes C

Language: Spanish
References: 12
Page: 488-490
PDF size: 41.44 Kb.

Text Extraction

No Abstract

REFERENCES

1. Bayer R, Wilkinson D. Directly observed therapy for tuberculosis: history of an idea. Lancet 1995; 345: 1545-8.

2. Franco-Paredes C, Agudelo C. Editorial Response: The Ever Expanding Clinical Spectrum of Tuberculosis. J Clin Rheumatol 2002; 8(1): 1-2.

3. Blower SM, Chou T. Modeling the emergence of the ‘hot zones’: tuberculosis and the amplification dynamics of drug resistance. Nature Med 2004; 10(10): 1111-16.

4. Kochi A. Tuberculosis control: is DOTS the health breakthrough of the 1990’s? World Health Forum 1997; 18; 225-32.

5. Farmer P. The major infectious diseases in the world – To treat or not to treat? N Engl J Med 2001; 345(3): 208-10.

6. Espinal MA, Kim SJ, Suarez PG, et al. Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries. JAMA 2000; 283: 2537-45.

7. Farmer P, Furin JJ, Shin SS. The clinical management of multidrug-resistant tuberculosis. J Respir Dis 2000; 21: 53-6.

8. Kim JY, Furin JJ, Shakow AD, et al. Treatment of multidrug-resistant tuberculosis (MDR-TB): new strategies for procuring second and third line drugs. Int J Tuberc Luna Dis 1999; 3(Suppl. 1): S81.

9. DeRiemer K, García-García ML, Bobadilla-del-Valle JM, Palacios-Martínez M, Martínez-Gamboa A, Small PM, Sifuentes-Osornio J, Ponce-de-León A. Does DOTS work in populations with drug resistant tuberculosis? Lancet 2005.

10. Garcia-Garcia ML, Ponce de Leon A, Jimenez-Corona ME, Palacios-Martinez M, Balandrazo-Campos S, Ferreyra-Reyes L, et al. Clinical consequences and transmissibility of drug-resistant tuberculosis in Southern Mexico. Arch Intern Med 2000; 160(5): 630-6.

11. Franco-Paredes C. Comment to the return of the white plague: global poverty and the new tuberculosis. JAMA 2004; 291(21): 2646-7.

12. Pablos-Mendez A, Raviglione MC, Laszlo A, Binkin N, Rieder HL, Bustreo F, et al. Global surveillance for antituberculosis drug resistance, 1994-1997. N Engl J Med 1998; 338(23): 1641-9.